Completed OBSERVATIONAL NCT06706466
Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.
Systemic Immune-Inflammation Index As a Predictor of Neoadjuvant Treatment Efficacy in Advanced Gastric Cancer Based on a Dynamic Clinical Model
Sponsor: Chang-Ming Huang, Prof.
Interventions
observational study
Updated 1 time since 2024 Last updated: Nov 22, 2024 Started: Jan 1, 2018 Primary completion: Dec 31, 2021 Completion: May 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06706466, this observational or N/A phase trial focuses on Gastric Cancers and Immunotherapy Gastrict Cancer and remains completed. Sponsored by Chang-Ming Huang, Prof., it has been updated 1 time since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Chang-Ming Huang, Prof.
Data source: Fujian Medical University
For direct contact, visit the study record on ClinicalTrials.gov .